DE69223802T2 - Heparinase Gen von Flavobacterium Heparinum - Google Patents

Heparinase Gen von Flavobacterium Heparinum

Info

Publication number
DE69223802T2
DE69223802T2 DE69223802T DE69223802T DE69223802T2 DE 69223802 T2 DE69223802 T2 DE 69223802T2 DE 69223802 T DE69223802 T DE 69223802T DE 69223802 T DE69223802 T DE 69223802T DE 69223802 T2 DE69223802 T2 DE 69223802T2
Authority
DE
Germany
Prior art keywords
gene
flavobacterium heparinum
heparinase
heparinase gene
orf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69223802T
Other languages
English (en)
Other versions
DE69223802D1 (de
Inventor
Ramnath Sasisekharan
Kelley Moremen
Charles Cooney
Joseph Zimmermann
Robert Langer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE69223802D1 publication Critical patent/DE69223802D1/de
Publication of DE69223802T2 publication Critical patent/DE69223802T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69223802T 1991-10-23 1992-10-22 Heparinase Gen von Flavobacterium Heparinum Expired - Lifetime DE69223802T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/783,706 US5714376A (en) 1991-10-23 1991-10-23 Heparinase gene from flavobacterium heparinum
PCT/US1992/009124 WO1993008289A1 (en) 1991-10-23 1992-10-22 HEPARINASE GENE FROM $i(FLAVOBACTERIUM HEPARINUM)

Publications (2)

Publication Number Publication Date
DE69223802D1 DE69223802D1 (de) 1998-02-05
DE69223802T2 true DE69223802T2 (de) 1998-05-20

Family

ID=25130160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69223802T Expired - Lifetime DE69223802T2 (de) 1991-10-23 1992-10-22 Heparinase Gen von Flavobacterium Heparinum

Country Status (9)

Country Link
US (2) US5714376A (de)
EP (1) EP0610408B1 (de)
JP (2) JP3880062B2 (de)
AT (1) ATE161578T1 (de)
CA (1) CA2122004C (de)
DE (1) DE69223802T2 (de)
ES (1) ES2111653T3 (de)
GR (1) GR3026205T3 (de)
WO (1) WO1993008289A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
AU703394B2 (en) * 1995-09-29 1999-03-25 Biomarin Pharmaceutical Inc. Use of heparinases to decrease inflammatory responses
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
EP1109919A2 (de) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Von heparinase i und ii abgeleitete heparinasen
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
US6235725B1 (en) 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
EP1266013B1 (de) * 2000-03-08 2014-10-15 Massachusetts Institute Of Technology Heparinase iii und deren verwendungen
DK1319183T3 (da) * 2000-09-12 2009-05-18 Massachusetts Inst Technology Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
JP2004523479A (ja) * 2000-10-18 2004-08-05 マサチューセッツ　インスティテュート　オブ　テクノロジー 多糖の肺送達に関する方法および産物
DE60334220D1 (de) * 2002-06-03 2010-10-28 Massachusetts Inst Technology Rationell konstruierte, von chondroitinase b abgeleitete lyasen
DE102005038418A1 (de) * 2005-08-12 2007-02-15 Dade Behring Marburg Gmbh Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente
US7767420B2 (en) * 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691613B2 (en) * 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
CN103992995B (zh) * 2014-06-05 2016-05-04 山东大学 一种高表达水溶性肝素酶i融合蛋白及其编码基因
CN110343691B (zh) * 2019-07-24 2023-10-31 宝锐生物科技泰州有限公司 突变型肝素酶ⅰ及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107584A (en) * 1978-02-10 1979-08-23 Seikagaku Kogyo Co Ltd Preparation of pure heparinase
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
IT1141249B (it) * 1980-02-28 1986-10-01 Italfarmaco Spa Procedimento per la preparazione di copolimeri di polisaccaridi supprotanti attivita' enzimatica,e copolimeri cosi' ottenuti
US4341869A (en) * 1980-08-25 1982-07-27 Massachusetts Institute Of Technology Process for producing heparinase
US4373023A (en) * 1980-10-14 1983-02-08 Massachusetts Institute Of Technology Process for neutralizing heparin
US4757012A (en) * 1983-06-28 1988-07-12 Genentech, Inc. Ascorbic acid intermediates and process enzymes
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US4795703A (en) * 1986-03-07 1989-01-03 The Children's Medical Center Corporation Heparin assay
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
JP2603349B2 (ja) * 1988-06-06 1997-04-23 マサチューセッツ インスティテュート オブ テクノロジー 高純度ヘパリナーゼの大規模精製法
JP2833793B2 (ja) * 1989-09-19 1998-12-09 科学技術振興事業団 ヘパリナーゼをコードするプラスミド、このプラスミドを保持するヘパリナーゼ生産株及びヘパリナーゼの製造法

Also Published As

Publication number Publication date
JP3880062B2 (ja) 2007-02-14
US5830726A (en) 1998-11-03
ATE161578T1 (de) 1998-01-15
CA2122004A1 (en) 1993-04-29
GR3026205T3 (en) 1998-05-29
EP0610408B1 (de) 1997-12-29
JP2004057201A (ja) 2004-02-26
CA2122004C (en) 2003-08-19
DE69223802D1 (de) 1998-02-05
ES2111653T3 (es) 1998-03-16
JPH07503608A (ja) 1995-04-20
EP0610408A1 (de) 1994-08-17
US5714376A (en) 1998-02-03
WO1993008289A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
ATE161578T1 (de) Heparinase gen von flavobacterium heparinum
IL80826A0 (en) Antigenic proteins,their production and their use in the prevention of coccidiosis
HK1013847A1 (en) Gdf-1 and uog-1 proteins
DK239383A (da) Mikrobiologisk fremstillede alfa- og beta-interferoner, dna-sekvenser, der koder for disse interferoner, mikroorganismer, som indeholder denne genetiske information, og fremgangsmaade til deres fremstilling
DE69433280D1 (de) Rekombinantes stratum corneum chymotypisches enzym ( scce)
SI1346034T1 (sl) POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
PT666914E (pt) Nova proteina ligando da selectina p
DK0433117T3 (da) Nye polypeptider, DNA-sekvenser, som muliggør ekspression deraf, samt fremstilling og anvendelse deraf.
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
TW342413B (en) Novel toxins isolated from Bracon Hebetor
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
EP0303997A3 (en) Acyl-peptide hydrolase and methods of production and use
DE60021707D1 (de) Beta-primeverosidase gen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 610408

Country of ref document: EP